Lion Point Capital, LP KNSA Holdings History
Lion Point Capital, LP's Kiniksa Pharmaceuticals International PLC Holding Summary
As of 2025-03-31, Lion Point Capital, LP held 45,900.00 shares of Kiniksa Pharmaceuticals International PLC(KNSA), totaling $1.02 Mil. This investment constitutes 6.5% of their stock portfolio, and Lion Point Capital, LP now holds 0.06% of the outstanding Kiniksa Pharmaceuticals International PLC(KNSA) stock.
The initial trade took place in 2020Q1. And since then Lion Point Capital, LP has made 3 purchases of KNSA, at an average price of $13.30, for a total of 937,899.00 shares. In addition, there have been 6 sales at an average price of $13.83 for 891,999.00 shares. Based on historical transaction data and KNSA's current price of $29.02, Lion Point Capital, LP's estimated gain on his KNSA holdings is $1.19 Mil, reflecting a 9.56% gain to date.
Lion Point Capital, LP KNSA ($29.02) Holding Chart
Lion Point Capital, LP KNSA ($29.02) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
